Hyperkalaemia
84 results
1 - 84
Hyperkalaemia 
Emergency interventions for hyperkalaemia- Emergency interventions for hyperkalaemia
- Pharmacological interventions for the acute management of hyperkalaemia in adults
- Treatment for hyperkalaemia in heart failure: a network meta‐analysis
- Interventions for non‐oliguric hyperkalaemia in preterm neonates
- Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
- Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
- Trimethoprim or trimethoprim-sulfamethoxazole and risk of hyperkalaemia among patients taking renin-angiotensin system blockers
- Acute kidney injury
- Hypokalaemia
- Drugs for chronic heart failure with preserved ejection fraction
- Normal saline versus lower‐chloride solutions for kidney transplantation
- Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
- Drug treatment for hypertension
- Rhabdomyolysis
- Addison's disease and other conditions inducing hypocortisolism
- Drugs commonly causing poisonings
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- Treatment of chronic renal failure
- Aldosterone antagonists for preventing the progression of chronic kidney disease
- Diabetic kidney disease (diabetic nephropathy)
- Hypertension in elderly patients
- Chronic heart failure
- Antihypertensive agents for preventing diabetic kidney disease
- Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking renin-angiotensin system blockers
- Antihypertensive agents for preventing diabetic kidney disease
- Prolonged storage of packed red blood cells for blood transfusion
- Increased blood creatinine concentration, eGFR and renal function tests
- Dialysis patient in primary health care
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis
- Secondary hypertension
- Dilated cardiomyopathy
- Early treatment with ACE inhibitors in acute myocardial infarction
- Blood transfusion: indications, administration and adverse reactions
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
- Low‐sodium salt substitutes and blood pressure
- Interpretation of adult ECG
- Urinary tract infections
- Acne
- Comprehensive treatment and follow-up of type 2 diabetes
- Acute heat illnesses
- Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- SGLT-2 inhibitors in type 2 diabetes
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Acute coronary syndrome
- Mental disorders due to somatic disease